Ratnatris Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 24 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with ARCSA (EC) and NAFDAC (NG). Its GMP standing is certified by CDSCO (India), ZAMRA (ZM) and TMDA (TZ), among 4 authorities. Customs aggregates show $314K of exports covering 49 molecules to 7 destinations in 2026 so far.
| Site | FDA FEI |
|---|---|
| Mehsana, India | Not on file |
| mehsana 382 715, India | Not on file |
| Mehsana, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| ARCSA (EC) | 19 | None |
| NAFDAC (NG) | 5 | 1 |
| CDSCO (India) | None | 2 |
| ZAMRA (ZM) | None | 1 |
| TMDA (TZ) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $314K | 7 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Ratnatris Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free